Sort by
Sort by

Infant formula product advisory

Nestlé has previously stated that all products on the market are safe to consume; how do you explain this recall months later after the global recall?

Quality, safety and compliance are non-negotiable at Nestlé.

This is an isolated incident. The recall is limited to two batches from a single production cycle in 2025. It is not a new instance of cereulide contamination.

While the levels detected by the Polish authorities from the production cycle concerned are compliant with and below the EU acute action threshold established by EFSA (the European Food Safety Authority) in February this year, we are taking this measure as mandated and in close cooperation with the relevant authorities.

Which countries are impacted? Do you expect more countries to be included in the recall?

The recall is limited to Poland, Lithuania, Latvia and Estonia.

No other ingredients, NAN batches or Nestlé products in any other countries are impacted.

You previously mentioned that the issue was related to ARA oil from a supplier whose ingredient has since been discontinued. Is there a new source or ingredient of concern?

Quality and food safety remain our highest priority.

The batches identified had been manufactured in December 2025, using ARA oil from Nestlé’s original and since discontinued supplier. It is not a new instance of cereulide contamination.

The impacted batches were released to the market on the basis of calculations which did not account for the fact that they were produced using two separate lots of ARA oil.

This recall is limited to these two batches from a single production cycle in 2025.

No other ingredients, NAN batches or Nestlé products in any other countries are impacted.

How can consumers continue to trust Nestlé that all remaining products on shelves are safe to consume? Have you updated your protocols and addressed the issues from the earlier recall?

We understand that news of an infant formula recall can be worrying for parents and caregivers. The health and wellbeing of babies remain our highest priority.

While the levels detected by the Polish authorities from the production cycle concerned are compliant with and below the EU acute action threshold established by EFSA (the European Food Safety Authority) in February this year, we are taking this measure as mandated and in close cooperation with the relevant authorities.

This is an isolated incident. The recall is limited to two batches from a single production cycle in 2025.

No other ingredients, NAN batches or Nestlé products in any other countries are impacted.

Since February 2026, all batches of LC PUFA oil mixes used in the manufacture of Nestlé Infant Formula products are systematically tested for cereulide to ensure conformity with applicable regulations and to guarantee food safety.

Why was cereulide not part of routine industry monitoring prior February 2026? Is there any regulation on accepted levels of cereulide in infant formula?

Nestlé was the first company to identify the cereulide related concern and to act, weeks before other manufacturers, in what became an industry-wide issue. We acted swiftly and responsibly to prioritize the health and wellbeing of infants.

Because its occurrence was considered extremely rare in oils, prior to 2026, testing for cereulide was not part of routine, legally required microbiological testing criteria.

On 2 February 2026, EFSA introduced new guidance with an action limit to manage cereulide risk in infant formula. The new acute reference dose corresponds to a product level of 0.43 ng/g.

We welcome EFSA's guidance in bringing greater clarity and consistency in managing cereulide risk across the entire infant formula industry.

What is your response to the ongoing investigations following the recall earlier this year?

We are deeply moved by the testimonies of the families affected.

At this stage, and as health authorities have reiterated, no medically confirmed link has been established between the consumption of recalled Nestlé infant formula products and any reported illness or fatalities.

We continue to follow developments with careful attention and remain at the disposal of the authorities, cooperating with complete transparency to provide any clarification required.

We cannot comment on specifics of ongoing legal proceedings.

Some NGOs argue Nestlé took too long to implement the initial recall in early 2026. What’s your response?

Nestlé acted compliantly and responsibly. See below for a comprehensive and factual account of the actions taken from initial detection to public recall.

Still have a question?